back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-02-27 Tx date 2018-02-26 |
$APS
Aptose Biosciences Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,750
-500 vol $3.50 each |
0 | |
| Filed 2018-01-23 Tx date 2018-01-19 |
$APS
Aptose Biosciences Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
110,750 | |
| Filed 2017-08-16 Tx date 2017-08-15 |
$APS
Aptose Biosciences Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$930.00
+500 vol $1.86 each |
500 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$APS
Aptose Biosciences Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,000 vol |
5,000 | |
| Filed 2017-06-30 Tx date 2013-06-27 |
$APS
Aptose Biosciences Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-30 Tx date 2017-06-28 |
$APS
Aptose Biosciences Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-5,000 vol |
0 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$APS
Aptose Biosciences Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,900
-5,000 vol $1.58 each |
0 | |
| Filed 2017-06-09 Tx date 2017-06-06 |
$APS
Aptose Biosciences Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,899
+5,000 vol $1.38 each |
50,750 | |
| Filed 2017-03-31 Tx date 2013-06-27 |
$APS
Aptose Biosciences Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-31 Tx date 2017-03-28 |
$APS
Aptose Biosciences Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
45,750 | |
| Filed 2017-03-31 Tx date 2017-03-28 |
$APS
Aptose Biosciences Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+5,000 vol |
5,000 | |
| Filed 2016-09-13 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Thompson, Bradley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+660,000 vol |
660,000 | |
| Filed 2016-09-13 Tx date 2003-04-04 |
$ONC
Oncolytics Biotech Inc. |
Thompson, Bradley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-04 Tx date 2016-03-31 |
$APS
Aptose Biosciences Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,200
+10,000 vol $3.82 each |
35,750 | |
| Filed 2015-12-02 Tx date 2015-12-01 |
$ONC
Oncolytics Biotech Inc. |
Thompson, Bradley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$510,720
+1,216,000 vol $0.42 each |
2,488,160 | |
| Filed 2015-10-06 Tx date 2015-10-02 |
$IMV
Immunovaccine Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$14,000
+35,000 vol $0.40 each |
70,000 | |
| Filed 2015-10-06 Tx date 2015-10-02 |
$IMV
Immunovaccine Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-14,000
-35,000 vol $0.40 each |
150,000 | |
| Filed 2015-09-17 Tx date 2015-09-15 |
$IMV
Immunovaccine Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,800
-35,000 vol $0.28 each |
185,000 | |
| Filed 2015-09-17 Tx date 2015-09-15 |
$IMV
Immunovaccine Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,800
+35,000 vol $0.28 each |
35,000 | |
| Filed 2015-09-17 Tx date 2011-06-22 |
$IMV
Immunovaccine Inc. |
Thompson, Bradley
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|